Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00678860 · ClinicalTrials.gov registry record
Validation of Computerized Vision-Targeted Quality-of-Life Questionnaires
A clinical trial of Eye Disease, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 147
- Enrollment target
- 1
- Study location
NCT00678860: Completed study of Eye Disease, sponsored by National Eye Institute (NEI).
NCT00678860 is a study of Eye Disease that has completed, run by National Eye Institute (NEI). The registered enrollment target is 147 participants, below the 361-participant average among 3 other Eye Disease trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00678860, a study of Eye Disease, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 147 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test and compare computerized and paper versions of eye questionnaires. Questionnaires are used in medicine to gain a better understanding of how a disease can impact a person's quality of life. Computerized versions of such questionnaires are often as good as or better than paper versions, but there has been no direct comparison of the two. This study may help in the development of eye questionnaires used to understand symptoms and monitor patients in clinical trials. People 21 years of age and older with ocular surface disease (OSD) and matched control subjects without OSD may be eligible for this study. All participants undergo the following procedures: * Medical and eye history. * Vision test and examination of the front part of the eye. * Tear measurement: A small piece of paper is placed on the surface of the eye to measure the amount of tears produced. The consistency of the tears is measured by looking at how fast they evaporate from the surface of the eye. * Completion of either paper-based or computer-based version of a questionnaire 15 minutes after the eye examination and completion of the other version within 1 week at home. (Subjects who complete the paper version in the clinic are told how to access the computer version online at home or on a library computer; those who complete the computer version in the clinic are given a paper version to take home.)
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2008-05-09 |
| Est. Completion | 2011-10-31 |
What the finished NCT00678860 record still lists
NCT00678860 is an observational study that tracks outcomes without assigning an intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 361-participant average among 3 other Eye Disease trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Eye Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00678860 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00678860 about?
NCT00678860 is a clinical study titled "Validation of Computerized Vision-Targeted Quality-of-Life Questionnaires". This study will test and compare computerized and paper versions of eye questionnaires. Questionnaires are used in medicine to gain a better understanding of how a disease can impact a person's quality of life. Computerized versions of such questionnaires are often as good as or better than paper ve...
What is the current status of trial NCT00678860?
This trial is currently completed. The enrollment target is 147 participants. The study started on 2008-05-09. Estimated completion is 2011-10-31.
What conditions does trial NCT00678860 study?
This clinical trial studies the following conditions: Eye Disease.
Who is sponsoring clinical trial NCT00678860?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00678860 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI